Living-donor liver transplantation for hepatoblastoma

American Journal of Transplantation

Volumn 5, Issue 9, 2005, Pages 2229-2235

  Kasahara, Mureo ^a   Ueda, Mikiko ^a   Haga, Hironori ^a   Hiramatsu, Hidefumi ^a   Kobayashi, Michihiro ^a   Adachi, Souichi ^a   Sakamoto, Seisuke ^a   Oike, Fumitaka ^a   Egawa, Hiroto ^a   Takada, Yasutsugu ^a   Tanaka, Koichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chemotherapy; Hepatectomy; Hepatoblastoma; Liver transplantation; Living donor

Indexed keywords

TACROLIMUS;

ADOLESCENT; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATOBLASTOMA; HUMAN; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROGNOSIS;

ALPHA-FETOPROTEINS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; HEPATOBLASTOMA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 27844520454     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01003.x     Document Type: Article

References (30)

1. Stocker JT, Ihsak KG. Hepatoblastoma. In: Okuda K, Ishak KG, eds. Neoplasms of the liver. New York: Springer-Verlag, 1987: 127-136.
2. Stocker JT. Hepatic tumors in children. In: Suchy FJ, ed. Liver disease in children. Missouri: Mosby-Year Book, 1994:901-928.
3. Stringer MD, Hennayake S, Howard ER et al. Improved outcome for children with hepatoblastoma. Br J Surg 1995; 82: 386-391.
4. Ninane J, Perilongo G, Stalens JP et al. Effectiveness and toxicity of cisplatin and doxorubisin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: a SIOP pilot study. Med Pediatr Oncol 1991; 19: 199-203.
5. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991; 110: 726-735.
6. Koneru B, Flye MW, Busuttil RW et al. Liver transplantation for hepatoblastoma: the American experience. Ann Surg 1991; 213: 118-121.
7. Tanaka K, Uemoto S, Tokunaga Y et al. Surgical techniques and innovations in living related liver transplantation. Ann Surg 1993; 217: 82-91.
8. Sasaki F, Matsunaga T, Iwafuchi M et al. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for pediatric Liver Tumor): a report from the Japanese study group for pediatric liver tumor. J Pediatr Surg 2002; 37: 851-856.
9. Suita S, Tajiri T, Mizote H et al. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen-a report from the study group for pediatric solid malignant tumors in the Kyusyu area. J Pediatr Surg 2004; 39: 195-199.
10. Matsunaga T, Sasaki F, Ohira M et al. Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma. Pediatr Surg Int 2003; 19: 142-146.
11. Tatekawa Y, Asonuma K, Uemoto S, Inomata Y, Tanaka K. Liver transplantation for biliary atresia associated with malignant hepatic tumors. J Pediatr Surg 2001; 36: 436-439.
12. Brown J, Perlingo G, Shafford E et al. Pretreatment prognostic factors for children with Hepatoblastoma-results from the International Society of Pediatric Oncology (SIOP). Study SIOPEL 1. Eur J Cancer 2000; 36: 1418-1425.
13. Kiuchi T, Kasahara M, Uryuhara K et al. Impact of graft-size mis-matching on graft prognosis in liver transplantation from living donors. Transplantation 1999; 67: 321-327.
14. Tanaka K, Uemoto S, Tokunaga Y et al. Surgical techniques and innovations in living related liver transplantation. Ann Surg 1993; 217: 81-92.
15. Pimpalwar AP, Sharif K, Ramani P et al. Strategy for hepatoblastoma management: transplant versus nontransplant surgery. J Pediatr Surg 2002; 37: 240-245.
16. Schweinitz VD, Hecker H, Schmidt VAG et al. Prognostic factors and staging systems in childhood hepatoblastoma. Int J Cancer 1997; 74: 593-599.
17. Reyes JD, Caerr B, Dvorcbik I et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 2000; 136: 795-804.
18. Molmenti EP, Wilkinson K, Molenti H et al. Treatment of unresectable Hepatoblastoma with liver transplantation in the pediatric population. Am J Transplant 2002; 2: 535-538.
19. Egawa H, Inomata Y, Uemoto S et al. Biliary anastomotic complications in 400 living related liver transplantation. World J Surg 2001; 25: 1300-1307.
20. Lionakis MS, Kontoyianmis DP. Glucocorticoids and invasive fungal infections. Lancet 2003; 362: 1828-1838.
21. Padbury RT, Toogood GJ, McMaster P. Withdrawal of immunosuppression in liver allograft recipients. Liver Transpl Surg 1998; 4: 242-248.
22. Feusner JH, Haas JE, Campbell JR, Lioyd DA, Ablin AR. Treatment of pulmonary metastasis of initial stage I hepatoblastoma in childhood. Report from the children cancer group. Cancer 1993; 71: 859-864.
23. Katzenstein HM, Rigsby C, Shaw PH et al. Novel therapeutic approaches in the treatment of children with hepatoblastoma. J Pediatr Hematol Oncol 2002; 24: 751-755.
24. Palmer RD, Williams DM. Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11). Med Pediatr Oncol 2003; 41: 78-80.
25. Nitschke R, Parkhurst J, Sullivan J et al. Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II study. J Pediatr Hematol Oncol 1998; 20: 315-318.
26. Blaney S, Berg SL, Pratt C et al. A phase I study of irinotecan in pediatric patients: a pediatric oncology group study. Clin Cancer Res 2001; 7: 32-37.
27. Tubergen DG, Stewart CF, Pratt CB et al. Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study. J Pediatr Hematol Oncol 1996; 18: 352-361.
28. Nakakura EK, Choti MA. Management of hepatocellular carcinoma. Oncology 2000; 14: 1085-1098.
29. Otte JB, Pritchard J, Aronson DC et al. Liver transplantation for hepatoblastoma: results from the international society of pediatric oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004; 42: 74-83.
30. Yoshinari M, Imaizumi M, Hayashi Y et al. Peripheral blood stem cell transplantation for hepatoblastoma with microscopic residue: a therapeutic approach for incompletely resected tumor. Tohoku J Exp Med 1998; 184: 247-254.